MedTrace Logo

Effects of a Progressive Adapted Physical Education Program on Muscular Strength and Endurance in Adolescents With Mild Intellectual Disability

NCT07599033 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-05-22

No results posted yet for this study

Summary

This randomized controlled trial investigated the effects of a 10-week progressive adapted physical education program on muscular strength and muscular endurance in adolescents with mild intellectual disability. Physical inactivity and reduced physical fitness are common among adolescents with intellectual disabilities and may negatively affect functional independence, health, and quality of life.

Participants were randomly assigned to either an intervention group or a control group. The intervention group participated in a structured adapted physical education program in addition to their regular school activities, while the control group continued their usual curriculum without additional exercise intervention. The program was implemented progressively over 10 weeks and included activities designed to improve upper-body strength, lower-body strength, core endurance, and overall muscular fitness.

Before and after the intervention period, participants completed physical fitness assessments evaluating muscular strength and endurance. The aim of this study was to determine whether a progressive adapted physical education program could improve physical fitness outcomes in adolescents with mild intellectual disability.

Conditions

  • Intellectual Disability, Mild
  • Muscular Strength

Interventions

BEHAVIORAL

Progressive Adapted Physical Education Program

A structured 10-week progressive adapted physical education program designed to improve muscular strength and muscular endurance in adolescents with mild intellectual disability. The intervention included exercises targeting upper-body strength, lower-body strength, trunk endurance, and general muscular fitness in addition to regular school activities.

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-05
Primary Completion
2026-03-16
Completion
2026-03-16

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07599033 on ClinicalTrials.gov